AM
VRTX icon

AGF Management’s Vertex Pharmaceuticals VRTX Stock Holding History

AGF Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Buy
207,971
+6,568
+3% +$2.91M 0.4% 72
2026
Q1 		$89.9M Buy
201,403
+200,835
+35,358% +$93.6M 0.4% 79
2025
Q4 		$258K Sell
568
-7,167
-93% -$3.09M ﹤0.01% 637
2025
Q3 		$3.03M Sell
7,735
-9,150
-54% -$3.82M 0.01% 434
2025
Q2 		$7.52M Buy
16,885
+5,402
+47% +$2.49M 0.03% 235
2025
Q1 		$5.57M Buy
11,483
+10,145
+758% +$4.73M 0.03% 248
2024
Q4 		$539K Sell
1,338
-1,347
-50% -$624K ﹤0.01% 624
2024
Q3 		$1.25M Buy
2,685
+1,429
+114% +$686K 0.01% 547
2024
Q2 		$589K Sell
1,256
-2,510
-67% -$1.09M ﹤0.01% 611
2024
Q1 		$1.57M Sell
3,766
-6,832
-64% -$2.89M 0.01% 520
2023
Q4 		$4.31M Sell
10,598
-3,591
-25% -$1.33M 0.03% 284
2023
Q3 		$4.93M Sell
14,189
-55
-0.4% -$19.2K 0.04% 251
2023
Q2 		$5.01M Sell
14,244
-2,108
-13% -$710K 0.04% 252
2023
Q1 		$5.15M Buy
16,352
+13,552
+484% +$4.06M 0.04% 266
2022
Q4 		$809K Buy
+2,800
New +$853K 0.01% 627

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AGF Management's VRTX Position: Q2 2026 in Review

AGF Management increased its Vertex Pharmaceuticals (VRTX) stake by 3.3% in Q2 2026, buying an estimated $2.91M and bringing the position to 207,971 shares worth $103M. The position accounts for 0.4% of the portfolio, ranked #72.

AGF Management first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. 1,756 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • AGF Management held 207,971 shares of Vertex Pharmaceuticals worth $103M as of Q2 2026.
  • AGF Management bought 6,568 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.91M.
  • Vertex Pharmaceuticals made up 0.4% of AGF Management's portfolio in Q2 2026, its #72 holding.
  • AGF Management first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 1,756 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.